Inserm1304_GETBO retweeted
Fantastic scientific meeting on 6th June 2026 in Brest by our research group @U1304GETBO, with brillant interventions, international leaders in VTE from @INNOVTE1, in Brest. 70 participants. @capucinsbrest, @FCRIN_network, CHU Brest, @UBO_UnivBrest , @Inserm, CIC1412 inserm.
Inserm1304_GETBO retweeted
@ASH_hematology Late Breaking Abstract:
Should patients receive extended duration anticoagulation with reduced or full dose DOAC for the secondary prevention of recurrent VTE - The RENOVE RCT presented by @FCouturaud
Reduced dose DOAC was not non inferior to full dose ((5-year cumulative incidence 2.2% vs 1.8%, P=0.23 for noninferiority) but lower risk of clinically relevant bleeding (9.9 vs 15.2%)! 🩸
Risk benefit seems to favor reduced dosing for most patients #ASH24
Inserm1304_GETBO retweeted
RENOVE trial: Full dose vs low dose extended anticoagulation in pts requiring long term AC.
Conclusions:
-similar low rate of recurrence (~2%) in both groups
-lower rate of bleeding w low dose
-a chance to compare DOAC efficacy (same!)
-caution w obesity
#ASH24 @FCouturaud
Inserm1304_GETBO retweeted
Extended-dose DOAC vs full-dose DOAC #Renove RCT #ASH24 Late breaking abstract. Officially, reduced dose was not non-inferior, but recurrent #VTE rates were low and there is a substantial reduction in major and non-major bleeding. Congrats to @FCouturaud & @INNOVTE1
Inserm1304_GETBO retweeted
Congratulations to @FoussardNinon for her remarkable thesis defense last week ! 🧑🎓We wish you the very best on your next adventure !
Inserm1304_GETBO retweeted
Fin de l'édition 2024 des Journée de #Recherche #Respiratoire . Merci aux orateurs et participants et un grand merci à Isabelle Vachier qui a coordonné avec brio RespirRent et organisé les J2R pendant plusieurs années. Elle passe la main à Bernard Mari et Christelle Guibert. 👏
Inserm1304_GETBO retweeted
Journées FCRIN @INNOVTE1 à l’HEGP, auditorium Guy Meyer. Une journée riche en projets, finalisés et à venir, cliniques et translationnels, nationaux et internationaux. Quel plaisir de poursuivre cette aventure ensemble!
Inserm1304_GETBO retweeted
Course connectée pour soutenir la #FondationduSouffle!! Belle journée à Brest pour réaliser le parcours!!
@U1304GETBO @CHRUBrest
@FduSouffle @FCouturaud
#UTBMontmartre
Inserm1304_GETBO retweeted
Our latest plasma proteomic study offers new evidence supporting the role of the complement cascade in thrombosis. @morange_pierre: @jac_ode. @GaelleMunsch @ELEANOR_BPH @JF2leuze. jthjournal.org/article/S1538…
Inserm1304_GETBO retweeted
Don't forget to apply to a travel grant to join us in Lille for the Printemps de la Cardiologie
@GRRC_SFCardio @SFCardio
Travel grant available for the next Printemps de la Cardiologie in Lille (July 1-3, 2024)
@GRRC_SFCardio @SFCardio
Inserm1304_GETBO retweeted
Deux super Offres de thèse de Science en méta-recherche à Saint-Etienne, auprès de @SilvyLaporte et @EdouardOllier @Sainbiose_Lab @Univ_St_Etienne
sfpt-fr.org/vie-de-la-sfpt/e…
Inserm1304_GETBO retweeted
Don't hesitate to apply and join our group.
We are looking for a highly motivated postdoc with understanding and expertise in cell biology, biochemistry and molecular analyses.
New post doc position in cell biology / CV diseases available @institut_thorax in the group of @CapouladeR
Inserm1304_GETBO retweeted
Travel grant available for the next Printemps de la Cardiologie in Lille (July 1-3, 2024)
@GRRC_SFCardio @SFCardio
Inserm1304_GETBO retweeted
Appel à candidature !!! Allocations de thèse de Science pour deux sujets en méta-recherche à Saint-Etienne
Projet RESTORES et projet BIAIS
Xmas lunch and farewell party for Marion Pilard on her last day in the lab.
Great time together! Merry christmas and all the best for 2024! 🎄🎅
@FCouturaud
@INNOVTE1 @InsermGrdOuest @UBO_UnivBrest @CatLemarie @GourdouV
Last Thursday was a special day for our team with the brilliant PhD defense of Marion Pilard!!
Congratulations Dr Pilard!
@InsermGrdOuest @UBO_UnivBrest @CatLemarie @FCouturaud @INNOVTE1
Inserm1304_GETBO retweeted
This review paper explores how organs-on-a-chip revolutionize the study of vascular diseases, offering
insights into drug discovery and personalized medicine
ahajrnls.org/3SfyEHN
